{"issuance_frequency":"","notes_translated":{"fr":"La présente ligne directrice a pour but d'harmoniser et de mettre à jour l'information d'ordonnance concernant les anti-inflammatoires non stéroïdiens (AINS) indiqués pour soulager la douleur et l'inflammation liées aux maladies rhumatismales et à d'autres affections moins graves. Chaque monographie doit contenir des renseignements objectifs, pertinents et concis sur les propriétés communes au principe actif et spécifiques au produit. Elle doit fournir les indications nécessaires à l'utilisation sûre et efficace du médicament, à l'intention non seulement du praticien, mais également du patient.","en":"This guidance is intended to harmonize and to update the prescribing information for nonsteroidal anti-inflammatory drugs () indicated for controlling pain and inflammation associated with rheumatic diseases and other less severe conditions. Each Product Monograph is expected to contain objective, adequate and concise information on properties common to the active component and specific to the drug product. It should provide guidance on the safe and effective use of the drug, not only to the practitioner but also to the patient."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"890923ca-76dd-48ce-98d2-d978580bfeec","metadata_created":"2021-07-07T16:51:47.340240","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-07-07T16:51:47.340246","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-07-07","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Informations de base sur la mMonographie du produit","les anti-inflammatoires non stéroïdiens","les AINS","le contrôle de la douleur et de l'inflammation","les maladies rhumatismales","la monographie du produit contient des informations objectives","adéquates et concises sur le produit médicamenteux","l'utilisation sûre et efficace du médicament"],"en":["Basic product mMonograph information","non-steroidal anti-inflammatory drugs","NSAIDs","controlling pain and inflammation","rheumatic diseases","product monograph contains objective","adequate and concise information on drug product","safe and effective use of the drug"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Information de base sur la monographie des anti-inflammatoires non stéroïdiens (AINS)","en":"Basic Product Monograph Information for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"890923ca-76dd-48ce-98d2-d978580bfeec","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b469c5d2-f09b-49e7-adb5-e974e2dc5423","related_relationship":"","name_translated":{"fr":"Information de base sur la monographie des anti-inflammatoires non stéroïdiens (AINS)","en":"Basic Product Monograph Information for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Basic Product Monograph Information for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)","language":["en"],"created":"2021-07-07T16:51:47.435922","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonsteroidal-anti-inflammatory-drugs-nsaids/guidance-document-basic-product-monograph-information-nonsteroidal-anti-inflammatory-drugs-nsaids.html#intro","last_modified":null,"position":0,"revision_id":"036b14bd-a94d-4c59-bc78-677aec888b7e","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"890923ca-76dd-48ce-98d2-d978580bfeec","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ae0645a4-8e4f-4604-9dc7-d3d3901e91dc","related_relationship":"","name_translated":{"fr":"Information de base sur la monographie des anti-inflammatoires non stéroïdiens (AINS)","en":"Basic Product Monograph Information for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Basic Product Monograph Information for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)","language":["fr"],"created":"2021-07-07T16:51:47.435929","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/anti-inflammatoires-non-steroidiens-ains/ligne-directrice-information-base-monographie-anti-inflammatoires-non-steroidiens-ains.html#intro","last_modified":null,"position":1,"revision_id":"036b14bd-a94d-4c59-bc78-677aec888b7e","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2009-08-07 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"890923ca-76dd-48ce-98d2-d978580bfeec","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"This guidance is intended to harmonize and to update the prescribing information for nonsteroidal anti-inflammatory drugs () indicated for controlling pain and inflammation associated with rheumatic diseases and other less severe conditions. Each Product Monograph is expected to contain objective, adequate and concise information on properties common to the active component and specific to the drug product. It should provide guidance on the safe and effective use of the drug, not only to the practitioner but also to the patient.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Basic Product Monograph Information for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)","revision_id":"036b14bd-a94d-4c59-bc78-677aec888b7e"}